BDNF and early-onset autosomal dominant Alzheimer disease: A significant correlation between serum BDNF levels and medial temporal lobe atrophy has been reported; therefore, decreased serum BDNF can potentially be used as a biomarker for early Alzheimer’s disease detection [39].